Djuna Von Maydell

Title: Djuna Von Maydell: Innovator in Alzheimer's Disease Research

Introduction

Djuna Von Maydell is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of neuroscience, particularly in understanding the role of APOE4 in myelination and its implications for Alzheimer's Disease. Her innovative research has the potential to pave the way for new therapeutic strategies.

Latest Patents

Djuna holds a patent titled "APOE4 impairs myelination via altered cholesterol biosynthesis and transport in oligodendroglia." This patent outlines methods for inhibiting amyloid synthesis in subjects using cyclodextrin and its analogs. The research demonstrates that small molecules like cyclodextrin can reverse APOE4-associated cholesterol phenotypes, leading to significantly improved myelination in both human in vitro cultures and APOE4 targeted replacement mice. This work uncovers a pathogenic role of APOE4 in oligodendrocytes and myelination, enabling new therapeutic opportunities for Alzheimer's Disease.

Career Highlights

Djuna is affiliated with the Massachusetts Institute of Technology, where she continues her groundbreaking research. Her work has garnered attention for its innovative approach to addressing the challenges posed by Alzheimer's Disease.

Collaborations

Djuna has collaborated with notable colleagues, including Joel Blanchard and Manolis Kellis, to advance her research and explore new avenues in the field of neuroscience.

Conclusion

Djuna Von Maydell's contributions to the understanding of APOE4 and its impact on myelination represent a significant advancement in Alzheimer's Disease research. Her innovative work holds promise for developing effective therapeutic strategies in the future.